Trademark: 87481623
Status Date
Wednesday, August 29, 2018
Filing Date
Thursday, June 8, 2017
Abandoned Date
Tuesday, July 31, 2018
44 Health care services, namely, cell immunotherapy; Medical services in the field of oncology; Medical services, namely, immunotherapy against cancer and infectious diseases; Medical treatment of cancer and infectious diseases; Providing personalized healthcare and medical information in the nature of cell immunotherapy; Healthcare; Medical clinic services; Medical clinics; Nursing, medical
The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
The wording DendriLife has no meaning in a foreign language.
Aug 29, 2018
Abandonment Notice Mailed - Failure To Respond
Aug 29, 2018
Abandonment - Failure To Respond Or Late Response
Jan 29, 2018
Notification Of Final Refusal Emailed
Jan 29, 2018
Final Refusal E-Mailed
Jan 29, 2018
Final Refusal Written
Jan 29, 2018
Teas/Email Correspondence Entered
Jan 29, 2018
Correspondence Received In Law Office
Jan 25, 2018
Assigned To Lie
Jan 12, 2018
Teas Response To Office Action Received
Jan 12, 2018
Teas Change Of Correspondence Received
Sep 8, 2017
Notification Of Non-Final Action E-Mailed
Sep 8, 2017
Non-Final Action E-Mailed
Sep 8, 2017
Non-Final Action Written
Sep 7, 2017
Assigned To Examiner
Jun 15, 2017
New Application Office Supplied Data Entered In Tram
Jun 12, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
